Streamlining Pediatric Atopic Dermatitis Care Across Inuit Nunangat: Cost Savings and In-Community IL-4/IL-13 Biologic Treatment Initiation

Abstract

Keywords

atopic dermatitis dupilumab cost-effectiveness Indigenous health Nunavik Nunavut Yukon Inuit Nunangat

Get full access to this article

View all access options for this article.

References

Indigenous Services Canada. Non-Insured Health Benefits (NIHB) Program Update—December 2021. Government of Canada; 2021. Accessed November 6, 2025. https://mkonation.com/mko/wp-content/uploads/December-2021-NIHB-Progam-Update-Final.pdf

Institut national d’excellence en santé et en services sociaux (INESSS). Dupixent—Dermatite Atopique (Enfants de 6 à 11 Ans): Avis au Ministre. INESSS; 2021. Accessed November 6, 2025. https://www.inesss.qc.ca/fileadmin/doc/INESSS/Inscription_medicaments/Avis_au_ministre/Decembre_2021/Dupixent_dermatite_pediatrique_2021_11.pdf

Indigenous Services Canada. Non-Insured Health Benefits Program: First Nations and Inuit Health Branch—Annual Report 2020-2021 (Internet). Government of Canada; 2022. Accessed November 6, 2025. https://www.sac-isc.gc.ca/eng/1645718409378/1645718500555

Cassivi

Carabin

Dorea

Rodriguez

Guilherme

Domestic access to water in a decentralized truck-to-cistern system: a case study in the Northern Village of Kangiqsualujjuaq, Nunavik (Canada). J Water Health. 2024;22(5):797-810. doi:10.2166/wh.2024.246

Nunivaat. The Cost of Living in Nunavik in 2016 (Revised and Expanded). Université Laval; 2016. Accessed November 6, 2025. https://www.nunivaat.org/doc/publication/the-cost-of-living-in-nunavik-in-2016-revised-and-expanded.pdf 2021

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB